Inequalities in lung cancer: a world of EGFR

Carbonnaux Mélodie, Souquet Pierre-Jean, Meert Anne-Pascale, Scherpereel Arnaud, Peters Matthew, Couraud Sébastien

Source: Eur Respir J 2016; 47:1502-1509
Journal Issue: May
Disease area: Thoracic oncology

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Carbonnaux Mélodie, Souquet Pierre-Jean, Meert Anne-Pascale, Scherpereel Arnaud, Peters Matthew, Couraud Sébastien. Inequalities in lung cancer: a world of EGFR. Eur Respir J 2016; 47:1502-1509

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Health inequalities in Europe: the situation for lung cancer
Source: Annual Congress 2012 - Update on Tallinn summit: health inequalities in Europe
Year: 2012


Smoking and lung cancer in Albania
Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer
Year: 2018


Smoking and lung cancer
Source: International Congress 2018 – Effect of tobacco use on health
Year: 2018

Pattern of lung cancer in elderly
Source: Eur Respir J 2003; 22: Suppl. 45, 254s
Year: 2003

Therapeutic management of non-small cell lung cancers in Tunisia
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


EGFR exon in lung cancer: Survival predictors?
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012


Epigenetics and lung cancer
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006


Risk factors for lung cancer worldwide
Source: Eur Respir J 2016; 48: 889-902
Year: 2016




Survival outcomes in advance non-small cell lung cancer – A developing country scenario
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011

Interval change in prevalence and survival from lung cancer in the west of Ireland
Source: Annual Congress 2006 - Lung cancer staging and miscellaneous
Year: 2006


Other cancers in lung cancer families are overwhelmingly smoking-related cancers
Source: ERJ Open Res, 3 (2) 00006-2017; 10.1183/23120541.00006-2017
Year: 2017



The cost of lung cancer in Turkey
Source: Eur Respir J 2004; 24: Suppl. 48, 303s
Year: 2004

EGF-receptor mutation in non-small cell lung cancer – Experiences by routine molecular testing in a German lung cancer centre
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

EGFR mutation in non-small cell lung cancer(NSCLC) in South Croatia
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015


Advanced non-small cell lung cancer (NSCLC): observation of chemotherapy in 5 European countries
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007


Differences in epidemiological and clinical features in non-small cell lung cancer (NSCLC) in never and ever smokers
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015


Surgery for elderly early-stage non-small cell lung cancer: less or more?
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019



Management of lung cancer in the elderly
Source: Eur Respir J 2006; 28: Suppl. 50, 751s
Year: 2006

Chemotherapy for lung cancer in Scotland: a national survey
Source: Eur Respir J 2002; 20: Suppl. 38, 465s
Year: 2002